Norihiro Koya
Fukuoka, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Profiling immunogenic neoantigen peptides elicited by personalized neoantigen vaccine in cancer patients.
Journal: Frontiers in immunology
Published: March 13, 2026
Neoantigen peptide-pulsed dendritic cell vaccine therapy after surgical treatment of pancreatic cancer: a retrospective study.
Journal: Frontiers in immunology
Published: February 05, 2025
Dendritic cell-derived exosomes induce monocyte antigen-presentation and immune amplification in neoantigen vaccine therapy.
Journal: Frontiers in immunology
Published: January 23, 2025
Contribution of pre-existing neoantigen-specific T cells to a durable complete response after tumor-pulsed dendritic cell vaccine plus nivolumab therapy in a patient with metastatic salivary duct carcinoma.
Journal: Immunological investigations
Published: September 06, 2021
Efficacy of Intranodal Neoantigen Peptide-pulsed Dendritic Cell Vaccine Monotherapy in Patients With Advanced Solid Tumors: A Retrospective Analysis.
Journal: Anticancer research
Published: May 22, 2021
PTPN3 expressed in activated T lymphocytes is a candidate for a non-antibody-type immune checkpoint inhibitor.
Journal: Cancer immunology, immunotherapy : CII
Published: February 20, 2019
Long-term survival of a patient with recurrent gallbladder carcinoma, treated with chemotherapy, immunotherapy, and surgery: a case report.
Journal: Surgical case reports
Published: May 21, 2018
Stage IV gastric cancer successfully treated by multidisciplinary therapy including chemotherapy, immunotherapy, and surgery: a case report.
Journal: Surgical case reports
Published: July 25, 2017
Last Updated: 09/26/2026